Stocktoria

Celcuity Inc. CELC

Nasdaq · stock · Services-Medical Laboratories · website · IPO 2017-09-20 · LEI

Celcuity Inc. financials (annual)

Revenue
2016201720182019202020212022202320242025
Net income
-$3.3M -$6.3M -$7.5M -$7.4M -$9.5M -$29.6M -$40.4M -$63.8M -$111.8M -$177.0M 2016201720182019202020212022202320242025
Free cash flow
-$2.9M -$5.2M -$6.7M -$5.6M -$7.2M -$20.4M -$36.2M -$53.9M -$83.7M -$153.5M 2016201720182019202020212022202320242025

Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
R&D expense$145.0M$104.2M$60.6M$35.3M$25.8M$7.7M$6.3M$6.3M$5.0M$3.1M
Operating income-$172.2M-$113.3M-$66.2M-$39.4M-$28.4M-$9.6M-$7.8M-$7.9M-$6.0M-$3.3M
Interest expense$5.3M$2.1M$1.3M$120$159$111$451,664$0
Income tax$0$0$0$0$0
Net income-$177.0M-$111.8M-$63.8M-$40.4M-$29.6M-$9.5M-$7.4M-$7.5M-$6.3M-$3.3M
EPS (diluted)$-3.79$-2.83$-2.69$-2.64
Operating cash flow-$153.3M-$83.5M-$53.8M-$36.0M-$20.3M-$7.1M-$6.0M-$6.1M-$4.9M-$2.9M
Free cash flow-$153.5M-$83.7M-$53.9M-$36.2M-$20.4M-$7.2M-$5.6M-$6.7M-$5.2M-$2.9M
Cash & equivalents$165.7M$22.5M$30.7M$24.6M$84.3M$11.6M$18.7M$15.9M$2.7M$5.9M
Total assets$466.6M$245.1M$191.2M$175.7M$85.9M$13.0M$20.3M$26.0M$32.0M$6.1M
Total liabilities$366.0M$129.5M$51.5M$41.9M$17.2M$1.3M$983,229$682,210$578,053$445,359
Shareholders' equity$100.6M$115.6M$139.8M$133.8M$68.7M$11.7M$19.3M$25.3M$31.4M$5.6M

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.